Castle Biosciences Inc. held its 2025 annual meeting of stockholders on May 22, 2025. Stockholders elected Kimberlee S. Caple and G. Bradley Cole as Class III Directors. An amendment to the company's Amended and Restated Certificate of Incorporation was approved, limiting the liability of certain officers to the extent permitted by law.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Castle Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001447362-25-000085), on May 23, 2025, and is solely responsible for the information contained therein.